Survival-time analysis of 31 cases with clinical remission.
| Patients with Clinical Remission | Control Group | χ2 | P | |
|---|---|---|---|---|
| 5-Year Overall Survivals (OS) | 100% (31/31) | 80.30% (53/66) | 5.46 | <0.05 |
| 5-Year Disease-free Survival Rate (DFS) | 100% (31/31) | 72.73% (48/66) | 0.53 | <0.05 |